International Patent: STABILIZED GLP-1 PEPTIDES AND DUAL AGONIST PEPTIDES AGAINST GLP-1R AND GIPR AND METHODS OF USE THEREOF

GENEVA, June 19 -- BIOMEDIT, INC. filed a patent application (US2025/055134) for “STABILIZED GLP-1 PEPTIDES AND DUAL AGONIST PEPTIDES AGAINST GLP-1R AND GIPR AND METHODS OF USE THEREOF”. With publication no. WO/2026/107057, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 14/605

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....